Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/216952
Peptide-Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The relative success of platinum (Pt)-based chemotherapycomes at the cost of severe adverse side effects and is associated with a highrisk of pro-oncogenic activation in the tumor microenvironment. Here, wereport the synthesis of C-POC, a novel Pt(IV) cell-penetrating peptideconjugate showing a reduced impact against nonmalignant cells. In vitro andin vivo evaluation using patient-derived tumor organoids and laser ablationinductively coupled plasma mass spectrometry indicates that C-POCmaintains robust anticancer efficacy while displaying diminished accumulationin healthy organs and reduced adverse toxicity compared to the standard Pt-based therapy. Likewise, C-POC uptake is significantlylowered in the noncancerous cells populating the tumor microenvironment. This results in the downregulation of versican, abiomarker of metastatic spreading and chemoresistance that we found upregulated in patients treated with standard Pt-basedtherapy. Altogether, our findings underscore the importance of considering the off-target impact of anticancer treatment on normalcells to improve drug development and patient care.
Matèries
Matèries (anglès)
Citació
Citació
LINARES, Jenniffer, VARESE, Monica, SALLENT, Anna, MÉNDEZ, Ana, PALOMO-PONCE, Sergio, IGLESIAS, Mar, BATLLE, Eduard, PISONERO, Jorge, MONTAGUT, Clara, GIRALT LLEDÓ, Ernest, LO RE, Daniele, CALON, Alexandre. Peptide-Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells. _Journal of Medicinal Chemistry_. 2023. Vol. 66, núm. 5, pàgs. 3348-3355. [consulta: 14 de gener de 2026]. ISSN: 0022-2623. [Disponible a: https://hdl.handle.net/2445/216952]